DATASET RE-READ 2026-11-2042 PROGRAMSNEXLIFE PRICES READ 2026-11-20EVERY FIGURE CARRIES ITS READ DATE
TopGLP1Providers.comverified price index
DATED PRICES

OrderlyMeds review: November 2026 prices, terms and what to verify

As of November 20, 2026, OrderlyMeds’s own page lists $299 tirzepatide and $149 semaglutide a month ("Same Price, Every Month"); new customers can get two months for $299 or $149. On this site’s computed price-and-transparency score it has 27.9 of 40 points, position 6 of 27 compounded programs.

Released · Last reviewed · how we verify

Check OrderlyMeds’s current prices ↗

What OrderlyMeds charges now

OrderlyMeds’s prices were read on its own page on November 20, 2026. This site compares programs on the all-in month-to-month price at the maintenance dose, which counts any required membership or program fee and leaves out first-month offers. A 28-day billing cycle means 13 charges a year, not 12.

OrderlyMeds, compounded GLP-1 prices read on its own page on November 20, 2026 (all-in: medication plus any required recurring fee; before tax)
MedicationMonth to month, all-inBilling basisLowest printed rateYear at month-to-month priceRead
Compounded tirzepatide$299per month$149 (2-month new-customer offer, $299)$3,588 (12 months)2026-11-20
Compounded semaglutide$149per month$74 (2-month new-customer offer, $149)$1,788 (12 months)2026-11-20

OrderlyMeds on the computed score

On this site’s computed price-and-transparency score it has 27.9 of 40 points, position 6 of 27 compounded programs. The score covers the two parts of our seven-category methodology that can be checked for every program on the same day: pricing transparency (20 points) and total annual cost (20 points). The full ranking is on the rankings page.

How the computed score is built for OrderlyMeds (prices read November 20, 2026; five checks at 4 points each, plus total annual cost scaled to the lowest year in the dataset)
CheckTirzepatideSemaglutide
prints a month-to-month priceyes (+4)yes (+4)
medication and care in one priceyes (+4)yes (+4)
same price at every doseyes (+4)yes (+4)
no membership feeyes (+4)yes (+4)
price read on its own page on November 20, 2026yes (+4)yes (+4)
Year at the month-to-month price$3,588$1,788
Total annual cost points5.7 of 2010.1 of 20
Score for this drug25.7 of 4030.1 of 40

FDA warning letters

FDA’s warning-letter index lists warning letter 728291 (dated June 8, 2026, subject “False & Misleading Claims/Misbranded (Telehealth)”) to OrderlyMeds; no close-out letter is listed. A warning letter is FDA’s formal notice of alleged violations, not a recall, ban or court finding.

Limitations: five things to get in writing before you pay

Ask for the all-in price at your current dose and at the maintenance dose; the amount charged today and whether it recurs monthly or is prepaid; the licensed pharmacy that fills the prescription; the cancellation and refund terms, word for word; and what happens to your price when the dose goes up. Compounded tirzepatide and semaglutide are not FDA-approved and are not the same products as Zepbound or Wegovy.

Frequently asked

Does OrderlyMeds charge a membership fee?

No required membership fee appeared on OrderlyMeds’s page when it was read on November 20, 2026; the figures above are the full recurring charge before tax.

Does OrderlyMeds take insurance?

Not for compounded medication. OrderlyMeds is a cash-pay program in this dataset (August 2026 capture), and insurers do not cover compounded GLP-1s. If your plan covers Zepbound or Wegovy, check that first, because a covered brand prescription usually costs less than any cash price.

Which states does OrderlyMeds serve?

OrderlyMeds’s published coverage in the August 2026 capture was: not published. Telehealth prescribing depends on state licensing and changes often, so confirm your state at the start of the intake. The state pages list what each program publishes.

OrderlyMeds tirzepatideOrderlyMeds semaglutideOrderlyMeds alternativesOrderlyMeds vs EdenOrderlyMeds vs Fifty 410OrderlyMeds vs FoundOrderlyMeds vs Henry MedsRankingsPrice databaseAll providers

Sources

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.